1. Home
  2. NREF vs ELDN Comparison

NREF vs ELDN Comparison

Compare NREF & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$15.25

Market Cap

244.2M

Sector

Real Estate

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.85

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NREF
ELDN
Founded
2019
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
244.2M
291.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
NREF
ELDN
Price
$15.25
$3.85
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$14.00
$8.50
AVG Volume (30 Days)
37.9K
1.3M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
13.95%
N/A
EPS Growth
N/A
30.67
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.47
N/A
P/E Ratio
$4.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.36
$1.35
52 Week High
$16.06
$4.60

Technical Indicators

Market Signals
Indicator
NREF
ELDN
Relative Strength Index (RSI) 57.99 57.51
Support Level $13.76 $2.52
Resistance Level $16.04 $4.60
Average True Range (ATR) 0.46 0.22
MACD -0.05 -0.04
Stochastic Oscillator 52.41 59.59

Price Performance

Historical Comparison
NREF
ELDN

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: